Physician profile
Jon Rainey
NPI 1730145103
$10,448.62
in general payments reported to CMS, 2019-2025
49 companies · $1,950 in 2025
The $1,950 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,449 · 2020: $366 · 2022: $1,005 · 2023: $2,489 · 2024: $3,189 · 2025: $1,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,628.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $999.82 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $962.59 | 2019-2025 | |
| Glaxosmithkline, LLC. | $813.49 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbvie INC. | $793.53 | 2019-2025 | |
| Lilly USA, LLC | $752.00 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $723.47 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $609.96 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $509.63 | 2019-2025 | Jardiance, Tradjenta, Ofev |
| E.R. Squibb & Sons, L.L.C. | $448.29 | 2019-2025 | Eliquis |
| Exact Sciences Corporation | $410.33 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $409.52 | 2022-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $278.76 | 2022-2025 | |
| Astellas Pharma US INC | $235.19 | 2019-2025 | Veozah, Myrbetriq |
| Xeris Pharmaceuticals, INC. | $230.33 | 2023-2025 | Gvoke Hypopen |
| Dynavax Technologies Corporation | $185.55 | 2022-2025 | Heplisav-B |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Rainey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.